Biliary tract cancer

BTC · Oncology · 1 drugs · 1 indications

Cancer of bile ducts, gallbladder, or ampulla. Includes cholangiocarcinoma.

Competitive Landscape (1 drugs)

Drug	Company	Mechanism	Modality	Route	Stage
Imfinzi	AZN	PD-L1 inhibitor	Antibody	IV	APPROVED

Indications (1)

Biliary tract cancer

Imfinzi APPROVED

Upcoming Catalysts

Imfinzi + Imjudo - Locoregional HCC - Ph3 - ToplineCLINICAL

AZNH1 2026

Imfinzi ± Imjudo - MIBC - Ph3 - ToplineCLINICAL

AZNH1 2026

Datroway + Imfinzi - NSCLC - Ph3 - Topline (TROPION-Lung08)CLINICAL

AZNH1 2026

Imfinzi - Early HCC - Ph3 - ToplineCLINICAL

AZNH2 2026

Data from Supabase · Updated 2026-03-24